Cite
HARVARD Citation
Gamucci, T. et al. (n.d.). A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and Maintenance Therapy as First‐Line for HER2‐Negative Metastatic Breast Cancer. Journal of cellular physiology. 232 (6), pp. 1571-1578. [Online].